Molecular Partners AG (MOLN)
NASDAQ: MOLN
· Real-Time Price · USD
3.76
0.18 (5.03%)
At close: Jun 27, 2025, 3:59 PM
3.74
-0.53%
After-hours: Jun 27, 2025, 04:04 PM EDT
5.03% (1D)
| Bid | 3.5 |
| Market Cap | 138.65M |
| Revenue (ttm) | 4.97M |
| Net Income (ttm) | -54.04M |
| EPS (ttm) | -2.08 |
| PE Ratio (ttm) | -1.81 |
| Forward PE | -2.32 |
| Analyst | n/a |
| Ask | 3.91 |
| Volume | 7,868 |
| Avg. Volume (20D) | 10,430 |
| Open | 3.67 |
| Previous Close | 3.58 |
| Day's Range | 3.63 - 3.83 |
| 52-Week Range | 3.36 - 12.22 |
| Beta | 0.52 |
About MOLN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MOLN
Website n/a
2 months ago
+2.94%
Molecular Partners shares are trading higher after...
Unlock content with
Pro Subscription
8 months ago
+14.18%
Molecular Partners shares are trading higher after the company announced its radio-DARPin therapy candidate MP0712 was supported by in vivo data presented at the European Association of Nuclear Medicine Congress. The first-in-human start and initial clinical data are expected in 2025.
